Status:
COMPLETED
Can Vitamin D Reduce Heart Muscle Damage After Bypass Surgery?
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Vitamin D Deficiency
Cardiomyopathies
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Background and study aim: Heart diseases are among the most common causes of death worldwide. A large proportion of deaths are caused by heart attacks (myocardial infarction), where blood flow to the...
Detailed Description
Enrollment started in June 2018 and was completed in December 2018. The inclusion criteria were as following: the patients referred for elective and isolated Coronary Artery Bypass Graft (CABG) using ...
Eligibility Criteria
Inclusion
- Candidate for first-time elective CABG surgery for coronary artery disease (CAD)
- Coronary artery surgery only (i.e. no valvular surgery)
- Cardiopulmonary pump used during surgery
- Vitamin D level below 30 ng/ml
Exclusion
- Renal failure or creatinine level \>1.5 mg/dl
- Previous use of vitamin D supplement
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 21 2019
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04323852
Start Date
September 1 2017
End Date
January 21 2019
Last Update
October 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
modarres Hospital
Tehran, Iran